These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7518157)

  • 1. Does alpha 1 microglobulin in urine predict renal function after transplantation?
    Preuss R; Riek R; Steinhoff J; Fricke L; Hoyer J; Sack K
    Transplant Proc; 1994 Jun; 26(3):1766-7. PubMed ID: 7518157
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical significance of albuminuria in renal transplantation.
    Yanagisawa T; Kuzuhara K; Nishimori S; Kurooka Y; Yamada A; Harihara Y; Yokota K; Ogura Y; Otsubo O; Inou T
    Transplant Proc; 1994 Aug; 26(4):2174-5. PubMed ID: 7915061
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of nifedipine on renal haemodynamics and urinary protein excretion in stable renal transplant recipients.
    Wilkie ME; Beer JC; Raftery MJ; Dawnay A; Barton C; Marsh FP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):612-5. PubMed ID: 8438435
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term improvement of chronic renal graft dysfunction in cyclosporine-treated patients by addition of azathioprine and reduction of cyclosporine.
    Kliem V; Repp H; Frei U
    Transplant Proc; 1994 Oct; 26(5):2553-5. PubMed ID: 7940788
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospective randomised study of the influence of cyclosporin on long-term renal allograft function.
    Rowe PA; Watson MA; McMillan MA; Briggs JD; Rodger RS; Junor BJ
    Transplant Proc; 1994 Oct; 26(5):2617-8. PubMed ID: 7940814
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes of bone metabolism indices in patients receiving immunosuppressive therapy including low doses of steroids after renal transplantation.
    Yun YS; Kim BJ; Hong SP; Lee TW; Lim CG; Kim MJ
    Transplant Proc; 1996 Jun; 28(3):1561-4. PubMed ID: 8658786
    [No Abstract]   [Full Text] [Related]  

  • 7. Cadaveric renal transplantation with cyclosporine monotherapy.
    Aikawa A; Sells RA; Bakran A; Tewari A
    Transplant Proc; 1994 Aug; 26(4):1915-6. PubMed ID: 8066623
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimal combination of immunosuppressive agents for renal transplantation: first report of a multicentre, randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and with triple therapy in cadaver renal transplantation. The Australian Collaborative Trials Committee.
    Hardie IR; Tiller DJ; Mahony JF; Miach PJ; Thomson NM; Thatcher GN; Rigby RJ; Menzies BL
    Transplant Proc; 1993 Feb; 25(1 Pt 1):583-4. PubMed ID: 8438424
    [No Abstract]   [Full Text] [Related]  

  • 9. Urinary alpha 1- and beta 2-microglobulin in light chain proteinuria.
    Honkanen E; Pettersson T; Teppo AM
    Clin Nephrol; 1995 Jul; 44(1):22-7. PubMed ID: 7554529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion from cyclosporine to azathioprine at 3 months after renal transplantation: long-term results.
    van Wezel HB; Hilbrands LB; Koene RA; Hoitsma AJ
    Transplant Proc; 1994 Oct; 26(5):2550-2. PubMed ID: 7940787
    [No Abstract]   [Full Text] [Related]  

  • 11. Posttransplant serum creatinine area under the curve predicts renal allograft outcome.
    Sumrani N; Hong J; Miles A; Markell M; Distant D; Fleishhacker J; Maursky V; Jean-Baptiste F; Sommer B
    Transplant Proc; 1996 Feb; 28(1):356-7. PubMed ID: 8644260
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of cyclosporine and azathioprine on GFR and renal histopathology 12 to 24 months after renal transplantation.
    Pedersen EB; Hansen HE; Olsen S
    Transplant Proc; 1992 Feb; 24(1):309-10. PubMed ID: 1539289
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomized controlled trial of complete steroid withdrawal in renal transplant patients receiving triple immunosuppression.
    Ratcliffe PJ; Firth JD; Higgins RM; Smith B; Gray DW; Morris PJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):590. PubMed ID: 8438427
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognosis of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisolone.
    Chu SH; Lai MK; Huang CC; Chuang CK; Chen HW; Chen CS
    Transplant Proc; 1994 Aug; 26(4):1981-2. PubMed ID: 8066641
    [No Abstract]   [Full Text] [Related]  

  • 15. A 1-year prospective randomized study in Korean living donor kidney transplant recipients: comparing cyclosporine monotherapy and cyclosporine/prednisolone during the maintenance phase of immunosuppression.
    Park K; Kim ST; Lee SR; Koh YB; Kim HC
    Transplant Proc; 1994 Aug; 26(4):1985-6. PubMed ID: 8066642
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and tolerability of Sandimmun Neoral vs Sandimmun in de novo renal transplant patients after 24 months' treatment. German Neoral Study Group.
    Buchholz B; Korn A
    Transplant Proc; 1996 Aug; 28(4):2187-8. PubMed ID: 8769195
    [No Abstract]   [Full Text] [Related]  

  • 17. Microalbuminuria or micro-alpha-1-microglobulinuria: which one is better predictor of the development of the secondary nephropathy?
    Marczewski KT; Dziemidok P; Grzywna R; Krawczyk W
    Clin Nephrol; 1996 Feb; 45(2):136-7. PubMed ID: 8846530
    [No Abstract]   [Full Text] [Related]  

  • 18. Pentoxifylline as an adjunct to cyclosporine-based immunosuppression does not improve the outcome of renal transplantation.
    Königsrainer A; Aichberger C; Riedmann B; Steurer W; Ofner D; Margreiter R
    Transplant Proc; 1995 Feb; 27(1):1062-3. PubMed ID: 7878805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pravastatin on renal transplant recipients treated with cyclosporine--4-year follow-up.
    Yoshimura N; Ohmori Y; Tsuji T; Oka T
    Transplant Proc; 1994 Oct; 26(5):2632-3. PubMed ID: 7940820
    [No Abstract]   [Full Text] [Related]  

  • 20. Conversion to sirolimus from cyclosporine may induce nephrotic proteinuria and progressive deterioration of renal function in chronic allograft nephropathy patients.
    Boratyńska M; Banasik M; Watorek E; Falkiewicz K; Patrzałek D; Szyber P; Klinger M
    Transplant Proc; 2006; 38(1):101-4. PubMed ID: 16504675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.